Log in to save to my catalogue

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development...

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1963356

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

About this item

Full title

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

Publisher

Canada: CMA Impact Inc

Journal title

Journal of psychiatry & neuroscience, 2007-09, Vol.32 (5), p.313-315

Language

English

Formats

Publication information

Publisher

Canada: CMA Impact Inc

More information

Scope and Contents

Contents

Deprenyl (l-N-propargyl,N-methylamphetamine, selegiline), a selective irreversible MAO-B inhibitor, was originally developed in the hope that it would be an effective antidepressant without the pressor effect ("cheese effect"), which can occur in patients on irreversible MAO-A inhibitors when foods containing tyramine are ingested.

Alternative Titles

Full title

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1963356

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1963356

Other Identifiers

ISSN

1180-4882

E-ISSN

1488-2434

DOI

10.1016/S1180-4882(07)50056-9

How to access this item